CVS Health Corporation $CVS Stake Lifted by Eurizon Capital SGR S.p.A.

Eurizon Capital SGR S.p.A. lifted its position in shares of CVS Health Corporation (NYSE:CVS) by 256.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 322,035 shares of the pharmacy operator’s stock after purchasing an additional 231,740 shares during the period. Eurizon Capital SGR S.p.A.’s holdings in CVS Health were worth $27,631,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in CVS Health during the 2nd quarter worth $12,747,462,000. State Street Corp grew its holdings in shares of CVS Health by 26.3% during the second quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock worth $7,751,205,000 after buying an additional 15,604,883 shares during the last quarter. Wellington Management Group LLP increased its position in CVS Health by 49.8% in the 2nd quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock valued at $3,496,725,000 after acquiring an additional 11,233,381 shares during the period. Bank of America Corp DE raised its stake in CVS Health by 148.0% during the 2nd quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock valued at $2,398,868,000 after acquiring an additional 13,836,701 shares during the last quarter. Finally, Pzena Investment Management LLC purchased a new stake in CVS Health during the 2nd quarter valued at approximately $1,217,558,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Trending Headlines about CVS Health

Investors following CVS have been watching these headlines:

• Neutral Sentiment: Wells Fargo lowered its price target to $112 from $123 but kept an Overweight rating, signaling a reduced valuation outlook while still seeing potential upside. Wells Fargo analyst rating
• Negative Sentiment: The separation may not ease political criticism: lawmakers and critics argue that retaining CVS’s other lucrative businesses, including its pharmacy-benefit operations, would leave key drug-pricing concerns unresolved. CVS is planning a huge corporate breakup after drug price criticism
• Negative Sentiment: Carving out the retail pharmacies could involve significant execution costs and operational risks, leaving uncertainty about whether the restructuring will deliver the anticipated value. Can CVS Health’s 2028 Split Unlock Value Despite Execution Risks?

CVS Health Price Performance

CVS stock opened at $89.37 on Friday. The firm has a market cap of $114.34 billion, a P/E ratio of 10.40, a price-to-earnings-growth ratio of 0.78 and a beta of 0.58. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.66 and a current ratio of 0.85. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The stock has a 50-day simple moving average of $89.65 and a 200-day simple moving average of $89.09.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 EPS for the quarter, topping the consensus estimate of $1.65 by $0.44. The business had revenue of $108.40 billion for the quarter, compared to analysts’ expectations of $104.72 billion. CVS Health had a return on equity of 13.65% and a net margin of 2.62%. The company’s revenue was up 5.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.60 earnings per share. On average, equities analysts predict that CVS Health Corporation will post 8.26 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd were issued a dividend of $0.6650 per share. The ex-dividend date of this dividend was Thursday, October 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.0%. CVS Health’s dividend payout ratio is 30.97%.

Analyst Upgrades and Downgrades

CVS has been the topic of a number of recent research reports. Weiss Ratings raised CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday. TD Cowen reissued a “buy” rating on shares of CVS Health in a research note on Wednesday, November 4th. Argus lifted their target price on shares of CVS Health from $104.00 to $114.00 and gave the company a “buy” rating in a report on Wednesday, August 19th. UBS Group dropped their price target on shares of CVS Health from $118.00 to $107.00 and set a “buy” rating on the stock in a research note on Thursday, November 5th. Finally, Barclays cut their price target on shares of CVS Health from $108.00 to $107.00 and set an “overweight” rating for the company in a report on Thursday, November 5th. Twenty-three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $107.54.

Insider Buying and Selling at CVS Health

In related news, EVP Prem Shah bought 23,855 shares of the company’s stock in a transaction on Friday, November 6th. The shares were purchased at an average cost of $83.89 per share, with a total value of $2,001,195.95. Following the completion of the transaction, the executive vice president directly owned 88,516 shares of the company’s stock, valued at approximately $7,425,607.24. This represents a 36.89% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.85% of the company’s stock.

CVS Health Company Profile

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.